Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

W81XWH-22-ARP-IDA: DOD, Autism Research Program, Idea Development Award

Closed Closed August 18, 2022 Opportunity W81XWH-22-ARP-IDA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2022.

• Total funding$3.5 million
• Expected awards4
• Cost sharingNot required
• Funding typeCooperative Agreement, Grant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The FY22 ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. Applications are strongly encouraged to address one of the FY22 ARP Career Development Award Areas of Interest or provide justification that the proposed research addresses a critical problem, question, or need in ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation. Important aspects of the FY22 ARP Idea Development Award are as follows: • Impact: The proposed research is expected to make an important and original contribution to advancing the understanding of ASD and ultimately lead to improved outcomes for individuals with ASD and their families/caregivers. The project’s impact on both ASD research and ASD care should be articulated even if clinical impact is not an immediate outcome. A statistical plan is an important aspect of the FY22 ARP Idea Development Award to demonstrate the significance of any research outcomes or findings. • Innovation: Research deemed innovative may represent a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research may be innovative in study concept, research methods or technology, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not considered innovative. • Personnel: Personnel are considered a crucial element of the FY22 ARP Idea Development Award. The study team should have experience in ASD research. Inclusion of a biostatistician in the study team is encouraged. • Research must be based on preliminary data: Although the proposed research must have direct relevance to ASD, the required preliminary data, which may include unpublished results from the laboratory of the Principal Investigators (PIs), research team, or collaborators named on the application, may be from outside the ASD research field. Research should also be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.